-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The laboratory of Dr.
"The nanoparticle we developed is a powerful new delivery system for genome editing of vascular endothelial cells, which can be used to treat many diseases, including acute respiratory distress syndrome caused by severe COVID-19," senior author of Lurie Children Dr.
Endothelial dysfunction is the root cause of many diseases, such as coronary artery disease, stroke, bronchopulmonary dysplasia and pulmonary hypertension
At this stage, Dr.
"Our nanoparticle delivery system for genome editing and transgene expression is also a huge advancement in cardiovascular research," Dr.
Magazine
Cell Reports